Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Malehorn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Future Oncology (London, England)|December 13, 2006
Multiple biomarker panels for early detection of ovarian cancerZoya R Yurkovetsky, Faina Y Linkov, David E Malehorn, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 22, 2009
Serum proteomics using mass spectrometryBrian L Hood, David E Malehorn, Thomas P Conrads, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 14, 2007
Serum proteomic patterns as a predictor of severity in acute pancreatitisGeorgios I Papachristou, David E Malehorn, Janette Lamb, et al.
Cancer Informatics|March 24, 2009
Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studiesJames Lyons-Weiler, Richard Pelikan, Herbert J Zeh, et al.
Human Mutation|July 23, 2003
Detection and assignment of TP53 mutations in tumor DNA using peptide mass signature genotypingCheryl A Telmer, Jiyan An, David E Malehorn, et al.
Applied Bioinformatics|November 29, 2005
Feature Selection for Classification of SELDI-TOF-MS Proteomic ProfilesMilos Hauskrecht, Richard Pelikan, David E Malehorn, et al.
Clinical Chemistry|July 26, 2003
Detection of cystic fibrosis mutations by peptide mass signature genotypingDavid E Malehorn, Cheryl A Telmer, Sherri B McEwen, et al.
Arthritis Research & Therapy|July 1, 2005
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapyTakako Miyamae, David E Malehorn, Bonnie Lemster, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|December 13, 2006
Multiple biomarker panels for early detection of ovarian cancerZoya R Yurkovetsky, Faina Y Linkov, David E Malehorn, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 22, 2009
Serum proteomics using mass spectrometryBrian L Hood, David E Malehorn, Thomas P Conrads, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 14, 2007
Serum proteomic patterns as a predictor of severity in acute pancreatitisGeorgios I Papachristou, David E Malehorn, Janette Lamb, et al.
Cancer Informatics|March 24, 2009
Assessing the statistical significance of the achieved classification error of classifiers constructed using serum peptide profiles, and a prescription for random sampling repeated studies for massive high-throughput genomic and proteomic studiesJames Lyons-Weiler, Richard Pelikan, Herbert J Zeh, et al.
Human Mutation|July 23, 2003
Detection and assignment of TP53 mutations in tumor DNA using peptide mass signature genotypingCheryl A Telmer, Jiyan An, David E Malehorn, et al.
Applied Bioinformatics|November 29, 2005
Feature Selection for Classification of SELDI-TOF-MS Proteomic ProfilesMilos Hauskrecht, Richard Pelikan, David E Malehorn, et al.
Clinical Chemistry|July 26, 2003
Detection of cystic fibrosis mutations by peptide mass signature genotypingDavid E Malehorn, Cheryl A Telmer, Sherri B McEwen, et al.
Arthritis Research & Therapy|July 1, 2005
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapyTakako Miyamae, David E Malehorn, Bonnie Lemster, et al.
Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.
Pageof 1